2-Imidazol-4-ylethylamin

Histamine Struktur
51-45-6
CAS-Nr.
51-45-6
Bezeichnung:
2-Imidazol-4-ylethylamin
Englisch Name:
Histamine
Synonyma:
2-(1H-Imidazol-4-yl)ethan-1-amine;2-(1H-Imidazol-4-yl)ethanamine;HISTAMIN;Eramin;Eramine;Ergamine;istamina;HIS ELISA;Theramine;HISTAMINE
CBNumber:
CB3326778
Summenformel:
C5H9N3
Molgewicht:
111.15
MOL-Datei:
51-45-6.mol

2-Imidazol-4-ylethylamin Eigenschaften

Schmelzpunkt:
83-84 °C (lit.)
Siedepunkt:
167 °C/0.8 mmHg (lit.)
Dichte
0.9902 (rough estimate)
Brechungsindex
1.4690 (estimate)
storage temp. 
-20°C
Löslichkeit
DMSO: 20 mg/ml; Ethanol: 10 mg/ml; PBS (pH 7.2): 10 mg/ml
pka
6.04(at 25℃)
Aggregatzustand
Solid
Farbe
White to light yellow
Wasserlöslichkeit
Soluble in water, alcohol, and hot chloroform.
Merck 
13,4739
BRN 
2012
Stabilität:
Hygroscopic
InChIKey
NTYJJOPFIAHURM-UHFFFAOYSA-N
LogP
-0.700
CAS Datenbank
51-45-6(CAS DataBase Reference)
NIST chemische Informationen
Histamine(51-45-6)
EPA chemische Informationen
Histamine (51-45-6)
Sicherheit
  • Risiko- und Sicherheitserklärung
  • Gefahreninformationscode (GHS)
Kennzeichnung gefährlicher Xn
R-Sätze: 22-36/37/38-42/43
S-Sätze: 22-26-36/37
RIDADR  UN 2811 6.1/PG 3
WGK Germany  3
RTECS-Nr. MS1050000
3-10-23
TSCA  Yes
HazardClass  6.1(b)
PackingGroup  III
HS Code  29332900
Giftige Stoffe Daten 51-45-6(Hazardous Substances Data)
Toxizität LD50 i.p. in mice: 2020 mg/kg (Nagai)
Bildanzeige (GHS) GHS hazard pictogramsGHS hazard pictograms
Alarmwort Achtung
Gefahrenhinweise
Code Gefahrenhinweise Gefahrenklasse Abteilung Alarmwort Symbol P-Code
H301 Giftig bei Verschlucken. Akute Toxizität oral Kategorie 3 Achtung GHS hazard pictogramssrc="/GHS06.jpg" width="20" height="20" /> P264, P270, P301+P310, P321, P330,P405, P501
H315 Verursacht Hautreizungen. Hautreizung Kategorie 2 Warnung GHS hazard pictogramssrc="/GHS07.jpg" width="20" height="20" /> P264, P280, P302+P352, P321,P332+P313, P362
H317 Kann allergische Hautreaktionen verursachen. Sensibilisierung der Haut Kategorie 1A Warnung GHS hazard pictogramssrc="/GHS07.jpg" width="20" height="20" /> P261, P272, P280, P302+P352,P333+P313, P321, P363, P501
H319 Verursacht schwere Augenreizung. Schwere Augenreizung Kategorie 2 Warnung GHS hazard pictogramssrc="/GHS07.jpg" width="20" height="20" /> P264, P280, P305+P351+P338,P337+P313P
H334 Kann bei Einatmen Allergie, asthmaartige Symptome oder Atembeschwerden verursachen. Sensibilisierung der Atemwege Kategorie 1 Achtung GHS hazard pictogramssrc="/GHS08.jpg" width="20" height="20" /> P261, P285, P304+P341, P342+P311,P501
H335 Kann die Atemwege reizen. Spezifische Zielorgan-Toxizität (einmalige Exposition) Kategorie 3 (Atemwegsreizung) Warnung GHS hazard pictogramssrc="/GHS07.jpg" width="20" height="20" />
Sicherheit
P280 Schutzhandschuhe/Schutzkleidung/Augenschutz tragen.
P302+P352 BEI BERÜHRUNG MIT DER HAUT: Mit viel Wasser/... (Hersteller kann, falls zweckmäßig, ein Reinigungsmittel angeben oder, wenn Wasser eindeutig ungeeignet ist, ein alternatives Mittel empfehlen) waschen.
P305+P351+P338 BEI KONTAKT MIT DEN AUGEN: Einige Minuten lang behutsam mit Wasser spülen. Eventuell vorhandene Kontaktlinsen nach Möglichkeit entfernen. Weiter spülen.

2-Imidazol-4-ylethylamin Chemische Eigenschaften,Einsatz,Produktion Methoden

R-Sätze Betriebsanweisung:

R22:Gesundheitsschädlich beim Verschlucken.
R36/37/38:Reizt die Augen, die Atmungsorgane und die Haut.
R42/43:Sensibilisierung durch Einatmen und Hautkontakt möglich.

S-Sätze Betriebsanweisung:

S22:Staub nicht einatmen.
S26:Bei Berührung mit den Augen sofort gründlich mit Wasser abspülen und Arzt konsultieren.
S36/37:Bei der Arbeit geeignete Schutzhandschuhe und Schutzkleidung tragen.

Chemische Eigenschaften

White to slightly yellow powder

History

Histamine is an important protein involved in many allergic reactions. Allergies are caused by an immune response to a normally innocuous substance (i.e. pollen, dust) that comes in contact with lymphocytes specific for that substance, or antigen. The history of histamine and the development of antihistamines have been reviewed in [Drugs of Today (1986) and the Journal of Allergy & Clinical Immunology]. Histamine was the first to be characterized of a series of biogenic amines that are released in the inflammatory process. As early as 1910, it was shown that histamine caused constriction of isolated guinea pig ileum and, subsequently, it was found that histamine induced a shock-like syndrome. In 1927 the presence of histamine in normal tissues was demonstrated. Attempts to reduce histamine manifestations led to the report, in 1933, that certain phenolic ethers inhibited histamine action. Toxicity precluded clinical use. In 1942 phenbenzamine (Antergan), C17H22N2, was the first antihistamine to be successfully used in humans.
In 1966, the name H1 was proposed for receptors blocked by the at that time known antihistamines. It was also speculated that the other actions of histamine were likely to be mediated by other histamine receptors. The existence of the H2 receptor was accepted in 1972 and the H3 receptor was recognized in rat brain in 1983. H3 receptors in the brain appear to be involved in the feedback control of both histamine synthesis and release, whereas release of various other neurotransmitters, eg, serotinin (5-HT), dopamine, noradrenaline, and acetylcholine, is also modulated. H3 receptor effects have also been demonstrated in various peripheral tissues and H3 agonists and antagonists are undergoing intensive study for therapeutic applications.

Verwenden

Histamine inhibits the synthesis of IL-2 and γ-IFN in peripheral blood mononuclear cells and lipopolysaccharide-induced synthesis of TNF-α in monocytes via H2?receptor activation. It is a powerful stimulant of gastric secretion, a constrictor of bronchial smooth muscle, a vasodilator, and also a centrally acting neurotransmitter.

Indications

Sinus problems, hay fever, bronchial asthma, hives, eczema, contact dermatitis, food allergies, and reactions to drugs are all allergic reactions associated with the release of histamine and other autocoids, such as serotonin, leukotrienes, and prostaglandins. Histamine release is frequently associated with various inflammatory states and may be increased in urticarial reactions, mastocytosis, and basophilia. Histamine also acts as a neurotransmitter in the central nervous system (CNS). Upon release from its storage sites, histamine exerts effects ranging from mild irritation and itching to anaphylactic shock and eventual death.

Definition

ChEBI: A member of the class of imidazoles that is 1H-imidazole substituted at position C-4 by a 2-aminoethyl group.

Biosynthese

Virtually all of the histamine found in individual organs and tissues is synthesized locally and stored in subcellular secretory granules. Within the tissues, the mast cells are the principal sites of storage; in the blood, the basophils serve this function. Histamine is also present in neurons of the CNS, where it acts as a neurotransmitter.
Histamine is synthesized from the amino acid histidine by an action of the enzyme histidine decarboxylase. Following synthesis, histamine is either rapidly inactivated or stored in the secretory granules of mast cells and basophils as an inactive complex with proteases and heparin sulfate or chondroitin sulfate.

Biologische Funktion

Histamine occurs in the brain, particularly in certain hypothalamic neurons, and evidence is strong that histamine is a neurotransmitter. Distribution of histamine, its synthetic enzyme (histidine decarboxylase), and methyl histamine (the major brain metabolite) is not uniform. Possible roles for histamine in the regulation of food and water intake, thermoregulation, hormone release, and sleep have been suggested.

Allgemeine Beschreibung

Histamine is a neurotransmitter produced by neurons of the posterior hypothalamus. In the brain, histamine is predominantly present in the gray matter.

Mechanism of action

Non–Antigen-Mediated Release of Histamine Histamine may be released from mast cells by mechanisms that do not require prior sensitization of the immune system. Drugs, high-molecular-weight proteins, venoms, and other substances that damage or disrupt cell membranes can induce the release of histamine. Any thermal or mechanical stress of sufficient intensity also will result in histamine release. Cytotoxic compounds, may release histamine as the result of disruption of cell membranes.

Pharmakologie

Histamine is found in animal tissues and venoms and in many bacteria and plants.Within the human body, the largest histamine concentrations are in the skin, lungs, and gastrointestinal mucosa, while concentrations are smaller in almost all other organs and tissues.Histamine is present in human plasma at relatively low concentrations (usually less than 0.5 ng/mL); in contrast, wholeblood levels can be as high as 30-fold greater. Substantial quantities of histamine are present in urine, with excretion rates varying from 10 to 40μg per 24 hours.

Clinical Use

Histamine has only minor uses in clinical medicine. In the past it was used to diagnose pernicious anemia, in which histamine fails to evoke the usual secretion of gastric acid. Histamine has been used to assess bronchial hyperreactivity, although this test may be quite hazardous for asthmatics. Today the main clinical use of histamine is as a positive control injection for allergy skin testing.

Nebenwirkungen

Sedation is the most frequent adverse reaction to the first-generation antihistamines. An additive effect on alertness and motor skills will result if alcohol or another depressant is taken with these drugs. Antimuscarinic effects caused by these drugs include dry mouth and respiratory passages, urinary retention, and dysuria. Nausea, vomiting, constipation or diarrhea, dizziness, insomnia, nervousness, and fatigue also have been reported. Drug allergy, especially after topical application, is fairly common.Tolerance to certain antihistamines may develop after prolonged administration. Teratogenic effects of the piperazine antihistamines have been shown in animal studies. Epidemiological studies have not shown such an association in humans. The effects of toxic doses of first-generation antihistamines, similar to those seen following atropine administration, include excitement, hallucinations, dry mouth, dilated pupils, flushing, convulsions, urinary retention, sinus tachycardia, coma, and death.
The second-generation H1-antagonists are often referred to as nonsedating antihistamines; however, doses above the usual therapeutic level can cause sleepiness in certain individuals.A more serious adverse effect of some earlier second-generation antihistamines is cardiotoxicity.

läuterung methode

It crystallises from *benzene or chloroform. [Beilstein 25 I 628, 25 II 302, 25 III/IV 2049.]

2-Imidazol-4-ylethylamin Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


2-Imidazol-4-ylethylamin Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 294)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Henan Tianfu Chemical Co.,Ltd.
+86-0371-55170693 +86-19937530512
info@tianfuchem.com China 21691 55
Shanghai Zheyan Biotech Co., Ltd.
18017610038
zheyansh@163.com CHINA 3620 58
career henan chemical co
+86-0371-86658258
sales@coreychem.com China 29914 58
Hubei Jusheng Technology Co.,Ltd.
18871490254
linda@hubeijusheng.com CHINA 28180 58
Chongqing Chemdad Co., Ltd
+86-023-61398051 +8613650506873
sales@chemdad.com China 39916 58
CONIER CHEM AND PHARMA LIMITED
+8618523575427
sales@conier.com China 47465 58
Zhengzhou Alfa Chemical Co.,Ltd
+8618530059196
sale04@alfachem.cn China 12468 58
TargetMol Chemicals Inc.
+1-781-999-5354 +1-00000000000
marketing@targetmol.com United States 19892 58
Hefei TNJ Chemical Industry Co.,Ltd.
0551-65418671
sales@tnjchem.com China 34572 58
ANHUI WITOP BIOTECH CO., LTD
+8615255079626
eric@witopchemical.com China 23556 58

51-45-6(2-Imidazol-4-ylethylamin)Verwandte Suche:


  • 2-(4-Imidazolyl)ethanamine
  • β-Aminoethylglyoxaline
  • 1H-Imidazole-4-ethanamine (9CI)
  • Eramine
  • Histamine (8CI)
  • 4-(2-aminoethyl)-imidazol
  • 4-Imidazoleethylamine
  • 5-Imidazoleethylamine
  • beta-Aminoethylglyoxaline
  • beta-Aminoethylimidazole
  • beta-Imidazolyl-4-ethylamine
  • Eramin
  • Ergamine
  • Ergotidine
  • Ethylamine, 2-imidazol-4-yl-
  • Free histamine
  • freehistamine
  • Imidazole, 4-(2-aminoethyl)-
  • Imidazole-4-ethylamine
  • 2-imidazol-4-ylethylamine
  • HIS ELISA
  • 2-(1H-iMidazol-5-yl)ethan-1-aMine
  • bis(phosphoric acid)
  • Histamine ,97%
  • Histamine,2-(4-Imidazolyl)ethylamine
  • 2-(1H-imidazol-5-yl)ethanamine
  • 2-(1H-imidazol-5-yl)ethylamine
  • Histamine 1H-Imidazole-4-ethanamine
  • istamina
  • Theramine
  • histamine free base crystalline
  • Histamine, Free Base
  • HISTAMINE,REAGENT
  • 2-(3H-imidazol-4-yl)ethanamine
  • 4-(2-Aminoethyl)-1H-imidazole
  • HISTAMINE BASE
  • HISTAMINE
  • L-HISTAMINE
  • AURORA KA-668
  • ART-CHEM-BB B028627
  • 1h-imidazole-4-ethanamine
  • 2-(4-IMIDAZOLYL)ETHYLAMINE
  • 2-(1H-IMIDAZOL-4-YL)-ETHYLAMINE
  • RARECHEM AL BW 0710
  • 2-imidazol-4-yl-ethylamin
  • Histamine Vetec(TM) reagent grade, >=97%
  • Histamine CRS
  • 1H-Imidazole-5-ethanamine
  • Histamine Solution, 100μg/mL
  • Histamine USP/EP/BP
  • Medetomidine Impurity 61
  • Histamine 51-45-6
  • 2-(1H-Imidazol-4-yl)ethan-1-amine
  • HISTAMIN
  • 2-(1H-Imidazol-4-yl)ethanamine
  • Histamine (Ergamine)
  • Rabbit Anti-Histamine antibody
  • 51-45-6
Copyright 2019 © ChemicalBook. All rights reserved